rs387907272, MYD88

N. diseases: 73
Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Waldenstrom Macroglobulinemia
CUI: C0024419
Disease: Waldenstrom Macroglobulinemia
15 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.100 1.000 53 2012 2019
Diffuse Large B-Cell Lymphoma
CUI: C0079744
Disease: Diffuse Large B-Cell Lymphoma
127 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.100 0.895 19 2013 2019
Malignant lymphoma - lymphoplasmacytic
10 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.100 0.944 18 2012 2019
Lymphoma
CUI: C0024299
Disease: Lymphoma
91 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.100 0.917 12 2013 2019
Chronic Lymphocytic Leukemia
CUI: C0023434
Disease: Chronic Lymphocytic Leukemia
291 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.080 1.000 8 2013 2019
Neoplasms
CUI: C0027651
Disease: Neoplasms
1644 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.080 1.000 8 2012 2019
Adult Diffuse Large B-Cell Lymphoma
CUI: C1332201
Disease: Adult Diffuse Large B-Cell Lymphoma
46 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.070 1.000 7 2013 2019
Adult Lymphoma
CUI: C1332206
Disease: Adult Lymphoma
66 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.070 1.000 7 2014 2019
B-Cell Lymphomas
CUI: C0079731
Disease: B-Cell Lymphomas
42 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.070 1.000 7 2013 2018
Childhood Lymphoma
CUI: C1332979
Disease: Childhood Lymphoma
66 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.070 1.000 7 2014 2019
IgM monoclonal gammopathy of uncertain significance
3 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.060 1.000 6 2013 2019
Lymphoproliferative Disorders
CUI: C0024314
Disease: Lymphoproliferative Disorders
14 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.060 0.833 6 2013 2015
Marginal Zone B-Cell Lymphoma
CUI: C1367654
Disease: Marginal Zone B-Cell Lymphoma
25 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.060 1.000 6 2013 2019
Monoclonal Gammopathy of Undetermined Significance
20 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.050 0.800 5 2012 2019
Multiple Myeloma
CUI: C0026764
Disease: Multiple Myeloma
865 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.050 1.000 5 2012 2018
Primary central nervous system lymphoma
4 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.050 1.000 5 2018 2019
Monoclonal Gammapathies
CUI: C1136085
Disease: Monoclonal Gammapathies
2 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.040 1.000 4 2012 2017
Splenic Marginal Zone B-Cell Lymphoma
4 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.040 0.750 4 2013 2017
Bing-Neel syndrome
CUI: C0270710
Disease: Bing-Neel syndrome
1 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.030 1.000 3 2014 2019
Carcinogenesis
CUI: C0596263
Disease: Carcinogenesis
355 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.030 1.000 3 2016 2018
Mucosa-Associated Lymphoid Tissue Lymphoma
13 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.030 0.667 3 2013 2017
Paraproteinemias
CUI: C0030489
Disease: Paraproteinemias
9 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.030 1.000 3 2015 2019
Activated B-cell type diffuse large B-cell lymphoma
2 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.020 1.000 2 2014 2014
Hematologic Neoplasms
CUI: C0376545
Disease: Hematologic Neoplasms
60 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.020 1.000 2 2014 2016
Leukemogenesis
CUI: C0598766
Disease: Leukemogenesis
25 0.572 0.520 3 38141150 stop lost T/C snv 5.2E-05 7.0E-06 0.020 1.000 2 2014 2020